| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | Salt |
| UNII: | 55F75LJQ0V |
| Parent Compound: | ANAMORELIN |
| InChI Key | VFYAEUWJFGTGGO-GHTUPXNNSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C31H43ClN6O3 |
| Molecular Weight | 583.18 |
| AlogP | 2.72 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 9.0 |
| Polar Surface Area | 114.77 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 40.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Ghrelin receptor agonist | PubMed |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Cachexia | 2 | D002100 | ClinicalTrials |
| Fatigue | 2 | D005221 | ClinicalTrials |
| Pancreatic Neoplasms | 2 | D010190 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2103794 |
| EPA CompTox | DTXSID70235443 |
| FDA SRS | 55F75LJQ0V |
| PubChem | 16072155 |
| SureChEMBL | SCHEMBL4535148 |